014HO01160 WINKEN

Print/PDF
Registration Name STARDELL VALIANT WINKEN-ET
Registration Number HOUSA000001881163
Primary NAAB Code 014HO01160
Secondary Code(s)
Status Inactive
Controller Name Select Sires - AG (14)
Date of Birth 8/7/1981
aAa -
DMS -
GFI 4.8%
Genetic Codes * TV TL TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire S-W-D VALIANT
MGS WHITTIER-FARMS APOLLO ROCKE
Beta Casein -
Kappa Casein -
Beta Lactoglobulin -
INDEXES
NM$ -909, 92% R CM$ -910
NM Percentile 01% FM$ -904
GTPI 1302 GM$ -936
PRODUCTION TRAITS
26788 Dtrs 6499 herds 100 % US 99% R
Milk -1889 Fat, % -77 , 0.00%
SCS 3, 99% R Protein, % -58 , +0.02%
Feed Saved -132 , 58% R Milking Speed 6.99 , 58% R
Health & Fertility
Productive Life -4.2      99% R Mastitis -1.4      88% R
Heifer Livability -0.2       57% R Metritis -1.3      83% R
Livability -1.2      99% R D. Abom 0.1      87% R
DPR -2.0      99% R Ketosis -0.9      81% R
FSC -9.6      99% R R. Placenta 0.0      84% R
HCR -1.1      90% R Milk Fever 0.0      69% R
CCR -3.4      98% R
SCR -        -
DIA 0.5      40% R
RSP 0.9      44% R
Calving Traits
Sire CE 1.0      99% R 16511 Obs
Daughter CE 2.3      99% R 21183 Obs, 10254 Dtrs
Sire SB 4.0      99% R 6509 Obs
Daughter SB 6.8      99% R 6521 Obs, Dtrs
Gestation Length -0.2      94% R 32 Obs, 46 Dtrs
Early First Calving -2.3      99% R 5636 Obs, 20988 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
9311 Dtrs 3523 herds 99% R
PTA Type -3.27 UDC -2.96
HCC -5.18 BWC 0.53
FLC -1.40
Linear Traits
Stature -2.87
Short
Strength -0.53
Weak
Body Depth -1.22
Shallow
Dairy Form -3.96
Closed
Rump Angle -1.08
Flat
Thurl Width -1.13
Flat
Rear Legs-Side View -1.13
Narrow
Rear Legs-Rear View -2.34
H.-in
Foot Angle -0.54
Low
Feet & Legs Score -1.82
Low
F.U. Attachment 1.13
Curved
Rear Udder Height -4.53
Low
Rear Udder Width -3.44
Narrow
Udder Cleft -1.95
Weak
Udder Depth -2.34
H.-in
Front Teat Placement -1.73
Wide
Rear Teat Placement -1.69
Wide
Teat Length -0.98
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO